ArticleSurgical endoscopy2025
Feasibility and safety of endoscopic full-thickness resection of large gastric subepithelial lesions outside the operating room: 10 years of experience in a large tertiary hospital in China.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSeveral studies have confirmed the safety and efficacy of endoscopic full-thickness resection (EFTR) of gastric subepithelial lesions (SELs), but many hospitals need to perform EFTR procedures in the operating room.
objectiveThe objective was to evaluate the safety and feasibility of EFTR of large (≥ 3 cm) gastric SELs outside the operating room based on our 10 years of experience.
methodsPatients with large gastric SELs who received EFTR from January 2013 to August 2023 were included. Univariate and multivariate logistic regression analyses were used to explore the risk factors for postoperative fever.
results81 patients were included. The average maximum diameter of tumor was 39.41 ± 9.34 mm, and 72 cases (88.9%) achieved en bloc resection. The average procedure time was 89.93 ± 49.80 min; no patients had postoperative hemorrhage or perforation. Follow-up showed no recurrence and metastasis. Multivariate regression analysis found that the tumor located in the middle and lower 1/3 of the stomach [odds ratio (OR) 3.208, 95% confidence interval (CI) 1.064-9.674; P = 0.038] and maximum diameter ≥ 39 mm (OR 3.136, 95% CI 1.105-8.900, P = 0.032) were risk factors for postoperative fever, while prophylactic antibiotic use (OR 0.249, 95% CI 0.066-0.941, P = 0.040) was a protective factor.
conclusionEFTR of gastric SELs outside the operating room is safe and feasible. Patients with tumors larger than 39 mm or in the lower middle third of the stomach are more likely to have postoperative fever, and prophylactic antibiotic use can reduce the risk.
Indexed as
Identifiers
40779132What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.